0.7436
price down icon3.20%   -0.0245
 
loading
前日終値:
$0.7681
開ける:
$0.7636
24時間の取引高:
319.96K
Relative Volume:
0.63
時価総額:
$89.14M
収益:
-
当期純損益:
$-198.64M
株価収益率:
-0.4619
EPS:
-1.61
ネットキャッシュフロー:
$-173.78M
1週間 パフォーマンス:
-5.95%
1か月 パフォーマンス:
-27.11%
6か月 パフォーマンス:
-66.36%
1年 パフォーマンス:
-49.42%
1日の値動き範囲:
Value
$0.74
$0.7736
1週間の範囲:
Value
$0.72
$0.8216
52週間の値動き範囲:
Value
$0.72
$5.195

Invivyd Inc Stock (IVVD) Company Profile

Name
名前
Invivyd Inc
Name
セクター
Healthcare (1195)
Name
電話
(781) 819-0080
Name
住所
1601 TRAPELO ROAD, WALTHAM
Name
職員
95
Name
Twitter
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
IVVD's Discussions on Twitter

IVVD を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
IVVD 0.7437 89.14M 0 -198.64M -173.78M -1.61
VRTX 450.27 115.43B 10.63B -479.80M -1.35B 13.33
REGN 748.65 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 590.61 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 247.57 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 107.17 24.89B 3.30B -501.07M 1.03B 11.54

Invivyd Inc Stock (IVVD) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2023-12-19 アップグレード Morgan Stanley Underweight → Equal-Weight
2023-05-01 開始されました H.C. Wainwright Buy

Invivyd Inc (IVVD) 最新ニュース

pulisher
Nov 20, 2024

Invivyd, Inc. (IVVD) Reports Q3 Loss, Misses Revenue Estimates - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

HC Wainwright Issues Pessimistic Forecast for Invivyd (NASDAQ:IVVD) Stock Price - MarketBeat

Nov 20, 2024
pulisher
Nov 16, 2024

Invivyd, Inc. (NASDAQ:IVVD) Short Interest Up 15.8% in October - MarketBeat

Nov 16, 2024
pulisher
Nov 15, 2024

Invivyd, Inc. (NASDAQ:IVVD) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 15, 2024
pulisher
Nov 15, 2024

Invivyd Inc (IVVD) Quarterly 10-Q Report - Quartz

Nov 15, 2024
pulisher
Nov 14, 2024

Invivyd’s Q3 2024: Revenue Growth and Strategic Developments - TipRanks

Nov 14, 2024
pulisher
Nov 14, 2024

IVVD stock touches 52-week low at $0.81 amid market challenges - Investing.com India

Nov 14, 2024
pulisher
Nov 14, 2024

Invivyd earnings missed by $0.18, revenue fell short of estimates - Investing.com Canada

Nov 14, 2024
pulisher
Nov 14, 2024

Invivyd, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 14, 2024
pulisher
Nov 14, 2024

Invivyd Reports Third Quarter 2024 Financial Results and Recent Business Highlights - The Manila Times

Nov 14, 2024
pulisher
Nov 14, 2024

Invivyd Announces New England Journal of Medicine Publishes Letter to the Editor Highlighting Immunobridging Pathway Leading to PEMGARDA™ (pemivibart) Emergency Use Authorization; Comments on Adjacent Third-Party Letter to the Editor - The Manila Times

Nov 14, 2024
pulisher
Nov 14, 2024

Invivyd's PEMGARDA Shows Promise Against COVID Variants Despite Lab Data Dispute | IVVD Stock News - StockTitan

Nov 14, 2024
pulisher
Nov 13, 2024

Invivyd Inc (IVVD) Q3 2024 Earnings Report Preview: What to Expect - Yahoo Finance

Nov 13, 2024
pulisher
Nov 13, 2024

Invivyd (IVVD) Set to Announce Earnings on Thursday - Defense World

Nov 13, 2024
pulisher
Nov 12, 2024

FMR LLC's Strategic Reduction in Invivyd Inc Shares - GuruFocus.com

Nov 12, 2024
pulisher
Nov 12, 2024

Invivyd Announces Preprints Conveying CANOPY Phase 3 Clinical Trial Data Including Long-Term Protection Versus Recent JN.1 Sublineages at Low Residual Titers, and Describing a Novel Approach for Predicting Monoclonal Antibody Activity Were Upload - The Manila Times

Nov 12, 2024
pulisher
Nov 12, 2024

Invivyd Announces Preprints Conveying CANOPY Phase 3 Clinical Trial Data Including Long-Term - The Bakersfield Californian

Nov 12, 2024
pulisher
Nov 12, 2024

Invivyd's COVID Drug Shows 84% Risk Reduction in Phase 3 Trial, Secures FDA Authorization | IVVD Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 06, 2024

Invivyd to Participate in the Guggenheim Securities Healthcare Innovation Conference - The Manila Times

Nov 06, 2024
pulisher
Nov 06, 2024

Invivyd to Participate in the Guggenheim Securities Healthcare Innovation Conference - GlobeNewswire Inc.

Nov 06, 2024
pulisher
Nov 06, 2024

Invivyd to Host Third Quarter 2024 Financial Results and Corporate Update Conference Call on November 14, 2024 - The Manila Times

Nov 06, 2024
pulisher
Nov 06, 2024

Invivyd (IVVD) Sets Q3 2024 Earnings Call: Financial Results & Business Updates Coming Nov 14 | IVVD Stock News - StockTitan

Nov 06, 2024
pulisher
Nov 02, 2024

EF Hutton Initiates Coverage of Invivyd (IVVD) with Buy Recommendation - MSN

Nov 02, 2024
pulisher
Nov 02, 2024

Invivyd (NASDAQ:IVVD) Upgraded at EF Hutton Acquisition Co. I - Defense World

Nov 02, 2024
pulisher
Nov 01, 2024

Invivyd (NASDAQ:IVVD) Upgraded by EF Hutton Acquisition Co. I to "Strong-Buy" Rating - MarketBeat

Nov 01, 2024
pulisher
Oct 30, 2024

Invivyd reports preliminary Q3 PEMGARDA product revenue $9.3M - MSN

Oct 30, 2024
pulisher
Oct 29, 2024

HC Wainwright Reiterates "Buy" Rating for Invivyd (NASDAQ:IVVD) - MarketBeat

Oct 29, 2024
pulisher
Oct 29, 2024

Invivyd Phase 3 Long-Term Exploratory Clinical Efficacy Data Shows PEMGARDA™ (pemivibart) Provided Substantial Protection from Symptomatic COVID-19 Versus Placebo Over Six Months of Follow-Up, With No Additional Doses, In Immunocompetent Part - The Manila Times

Oct 29, 2024
pulisher
Oct 29, 2024

Invivyd, Inc. Withdraws Financial Guidance for the Year 2024 - Marketscreener.com

Oct 29, 2024
pulisher
Oct 27, 2024

Head to Head Review: Prime Medicine (NYSE:PRME) and Invivyd (NASDAQ:IVVD) - Defense World

Oct 27, 2024
pulisher
Oct 16, 2024

Invivyd, Inc. (NASDAQ:IVVD) Short Interest Update - MarketBeat

Oct 16, 2024
pulisher
Oct 16, 2024

Guggenheim upgrades Invivyd Inc (IVVD) stock to a Buy - Knox Daily

Oct 16, 2024
pulisher
Oct 16, 2024

Invivyd to Present PEMGARDA™ (pemivibart) Data at Infectious Disease Week (IDWeek) 2024 - The Manila Times

Oct 16, 2024
pulisher
Oct 01, 2024

Point72 Asia Singapore Pte. Ltd. Sells 40,079 Shares of Invivyd, Inc. (NASDAQ:IVVD) - Defense World

Oct 01, 2024
pulisher
Oct 01, 2024

Invivyd Announces U.S. FDA Has Updated the PEMGARDA™ EUA Fact Sheet with Accurate SARS-CoV-2 Variant Susceptibility and PEMGARDA Activity Data - The Manila Times

Oct 01, 2024
pulisher
Sep 26, 2024

Invivyd Inc: Rising -81.14% from 52-Week Low, Can the Stock Stay Afloat? - The InvestChronicle

Sep 26, 2024
pulisher
Sep 26, 2024

Invivyd Inc [IVVD] Records 200-Day SMA of $2.5044 - Knox Daily

Sep 26, 2024
pulisher
Sep 26, 2024

Duquesne Family Office LLC Takes $629,000 Position in Invivyd, Inc. (NASDAQ:IVVD) - MarketBeat

Sep 26, 2024
pulisher
Sep 24, 2024

Take off with Invivyd Inc (IVVD): Get ready for trading - SETE News

Sep 24, 2024
pulisher
Sep 23, 2024

Invivyd reports stable pemivibart potency against SARS-CoV-2 By Investing.com - Investing.com Canada

Sep 23, 2024
pulisher
Sep 23, 2024

Invivyd reports stable pemivibart potency against SARS-CoV-2 - Investing.com

Sep 23, 2024
pulisher
Sep 23, 2024

Invivyd Inc (IVVD) is a good investment, but the stock may be undervalued - US Post News

Sep 23, 2024
pulisher
Sep 23, 2024

Investor’s Toolkit: Key Ratios for Assessing Invivyd Inc (IVVD)’s Performance - The Dwinnex

Sep 23, 2024
pulisher
Sep 23, 2024

Invivyd Provides Detailed Virology Data and Analysis of SARS-CoV-2 Structural Biology Predicting Anticipated Neutralization Activity for PEMGARDA™ (pemivibart) - ForexTV.com

Sep 23, 2024
pulisher
Sep 23, 2024

Invivyd (IVVD) Provides Detailed Virology Data and Analysis of SARS-CoV-2 Structural Biology Predicting Anticipated Neutralization Activity for PEMGARDA - StreetInsider.com

Sep 23, 2024
pulisher
Sep 23, 2024

Invivyd Provides Detailed Virology Data and Analysis of SARS-CoV-2 Structural Biology Predicting Anticipated - Daily Guardian Canada

Sep 23, 2024
pulisher
Sep 22, 2024

Invivyd, Inc.(NasdaqGM: IVVD) dropped from S&P Global BMI Index - Marketscreener.com

Sep 22, 2024
pulisher
Sep 18, 2024

Acadian Asset Management LLC Acquires 474,301 Shares of Invivyd, Inc. (NASDAQ:IVVD) - MarketBeat

Sep 18, 2024
pulisher
Sep 18, 2024

Biotech Co. Escapes Stock-Drop Suit Over COVID-19 Drug - Law360

Sep 18, 2024
pulisher
Sep 16, 2024

Invivyd Inc (IVVD)’s highs and lows: A closer look at its stock price fluctuations - US Post News

Sep 16, 2024
pulisher
Sep 14, 2024

We're Keeping An Eye On Invivyd's (NASDAQ:IVVD) Cash Burn Rate - Yahoo Finance

Sep 14, 2024

Invivyd Inc (IVVD) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Invivyd Inc (IVVD) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Adimab, LLC
10% Owner
Jan 19 '24
Sale
3.95
5,000,000
19,750,000
21,687,906
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
大文字化:     |  ボリューム (24 時間):